Skip to main content
Earnings Labs
Atrium Therapeutics, Inc. logo

Atrium Therapeutics, Inc. (RNA)

NASDAQ·Healthcare·Biotechnology

$8.24

+2.36%

Mkt Cap $142.49M

Analyst Ratings

Buy

1

Hold

0

Sell

0

Price Target (3 analysts)

$25.00

Range $25.00 – $25.00

Implied Upside

+203.4%

Consensus $25.00 vs current $8.24